Tapewire

Nasdaq · USD

ADTN

ADTRAN Holdings, Inc.

Export transactions ↓
Tapewire entity
5331
SEC CIK
0000926282
Parsed reports
653

Last 12 months

Inside the activity.

4 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 15, 2020 Filed Nov 16, 2020 22:50 UTC
Kimpe MarcSVP, Research & Development
Tax withholdingCommon Stock 691 $12.65 $8,741.15
Disclosure

SEC source: 0000926282-20-000031 · primary_doc.xml · nonDerivative · entry 2

Kimpe Marc · CIK 0001770330 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,544

Read SEC document
November 15, 2020 Filed Nov 16, 2020 19:50 UTC
Centis RonaldSVP, Operations
Tax withholdingCommon Stock 726 $12.65 $9,183.90
Disclosure

SEC source: 0000926282-20-000029 · primary_doc.xml · nonDerivative · entry 1

Centis Ronald · CIK 0001769038 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,049.76

Read SEC document
November 15, 2020 Filed Nov 16, 2020 20:39 UTC
Scheiterer EduardSVP, Research & Development
Tax withholdingCommon Stock 677 $12.65 $8,564.05
Disclosure

SEC source: 0000926282-20-000030 · primary_doc.xml · nonDerivative · entry 2

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,077

Read SEC document
November 15, 2020 Filed Nov 16, 2020 19:26 UTC
STANTON THOMAS RDirector · Chairman and CEO
Tax withholdingCommon Stock 6,154 $12.65 $77,848.10
Disclosure

SEC source: 0000926282-20-000026 · primary_doc.xml · nonDerivative · entry 2

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,437

Read SEC document
November 15, 2020 Filed Nov 16, 2020 19:35 UTC
Wilson James Denson JrChief Revenue Officer
Tax withholdingCommon Stock 1,086 $12.65 $13,737.90
Disclosure

SEC source: 0000926282-20-000027 · primary_doc.xml · nonDerivative · entry 2

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,364

Read SEC document
November 15, 2020 Filed Nov 16, 2020 19:42 UTC
Foliano MichaelChief Financial Officer
Tax withholdingCommon Stock 1,070 $12.65 $13,535.50
Disclosure

SEC source: 0000926282-20-000028 · primary_doc.xml · nonDerivative · entry 2

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,644

Read SEC document
November 12, 2020 Filed Nov 16, 2020 22:50 UTC
Kimpe MarcSVP, Research & Development
Tax withholdingCommon Stock 259 $12.39 $3,208.47
Disclosure

SEC source: 0000926282-20-000031 · primary_doc.xml · nonDerivative · entry 1

Kimpe Marc · CIK 0001770330 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,235

Read SEC document
November 12, 2020 Filed Nov 16, 2020 20:39 UTC
Scheiterer EduardSVP, Research & Development
Tax withholdingCommon Stock 312 $12.33 $3,846.96
Disclosure

SEC source: 0000926282-20-000030 · primary_doc.xml · nonDerivative · entry 1

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,754

Read SEC document
November 12, 2020 Filed Nov 16, 2020 19:26 UTC
STANTON THOMAS RDirector · Chairman and CEO
Tax withholdingCommon Stock 2,134 $12.33 $26,312.22
Disclosure

SEC source: 0000926282-20-000026 · primary_doc.xml · nonDerivative · entry 1

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,591

Read SEC document
November 12, 2020 Filed Nov 16, 2020 19:35 UTC
Wilson James Denson JrChief Revenue Officer
Tax withholdingCommon Stock 475 $12.33 $5,856.75
Disclosure

SEC source: 0000926282-20-000027 · primary_doc.xml · nonDerivative · entry 1

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,450

Read SEC document
November 12, 2020 Filed Nov 16, 2020 19:42 UTC
Foliano MichaelChief Financial Officer
Tax withholdingCommon Stock 375 $12.33 $4,623.75
Disclosure

SEC source: 0000926282-20-000028 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,714

Read SEC document
November 11, 2020 Filed Nov 13, 2020 00:56 UTC
Scheiterer EduardSVP, Research & Development
Tax withholdingCommon Stock 269 $12.51 $3,365.19
Disclosure

SEC source: 0000926282-20-000024 · primary_doc.xml · nonDerivative · entry 2

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,066

Read SEC document
November 11, 2020 Filed Nov 13, 2020 01:03 UTC
Kimpe MarcSVP, Research & Development
Tax withholdingCommon Stock 257 $12.51 $3,215.07
Disclosure

SEC source: 0000926282-20-000025 · primary_doc.xml · nonDerivative · entry 2

Kimpe Marc · CIK 0001770330 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,494

Read SEC document
November 11, 2020 Filed Nov 13, 2020 00:48 UTC
Wilson James Denson JrChief Revenue Officer
Tax withholdingCommon Stock 431 $12.51 $5,391.81
Disclosure

SEC source: 0000926282-20-000023 · primary_doc.xml · nonDerivative · entry 2

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,925

Read SEC document
November 11, 2020 Filed Nov 13, 2020 00:41 UTC
Foliano MichaelChief Financial Officer
Tax withholdingCommon Stock 327 $12.51 $4,090.77
Disclosure

SEC source: 0000926282-20-000022 · primary_doc.xml · nonDerivative · entry 2

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,089

Read SEC document
November 11, 2020 Filed Nov 13, 2020 00:24 UTC
STANTON THOMAS RDirector · Chairman and CEO
Tax withholdingCommon Stock 2,003 $12.51 $25,057.53
Disclosure

SEC source: 0000926282-20-000021 · primary_doc.xml · nonDerivative · entry 2

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,725

Read SEC document
November 11, 2020 Filed Dec 3, 2020 21:22 UTC Amendment
STANTON THOMAS RDirector · Chairman and CEO
GrantPhantom Stock · Derivative 0 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000047 · primary_doc.xml · derivative · entry 4

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,830.706

Underlying: Common Stock · 0 shares

Expires not disclosed

F1 · derivative.exercise_price: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · derivative.exercise_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · derivative.expiration_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · derivative.underlying_shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

F1 · balance_after: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction.

Read SEC document
November 11, 2020 Filed Dec 3, 2020 21:22 UTC Amendment
STANTON THOMAS RDirector · Chairman and CEO
Tax withholdingCommon Stock 8,295 $12.51 $103,770.45
Disclosure

SEC source: 0000926282-20-000047 · primary_doc.xml · nonDerivative · entry 2

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,090

Read SEC document
November 11, 2020 Filed Dec 3, 2020 17:36 UTC
Scheiterer EduardSVP, Research & Development
Tax withholdingCommon Stock 738 $12.51 $9,232.38
Disclosure

SEC source: 0000926282-20-000046 · primary_doc.xml · nonDerivative · entry 1

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,578

Read SEC document
November 09, 2020 Filed Nov 13, 2020 00:56 UTC
Scheiterer EduardSVP, Research & Development
Tax withholdingCommon Stock 421 $11.77 $4,955.17
Disclosure

SEC source: 0000926282-20-000024 · primary_doc.xml · nonDerivative · entry 1

Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,335

Read SEC document
November 09, 2020 Filed Nov 13, 2020 01:03 UTC
Kimpe MarcSVP, Research & Development
Tax withholdingCommon Stock 404 $11.77 $4,755.08
Disclosure

SEC source: 0000926282-20-000025 · primary_doc.xml · nonDerivative · entry 1

Kimpe Marc · CIK 0001770330 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,751

Read SEC document
November 09, 2020 Filed Nov 13, 2020 00:48 UTC
Wilson James Denson JrChief Revenue Officer
Tax withholdingCommon Stock 674 $11.77 $7,932.98
Disclosure

SEC source: 0000926282-20-000023 · primary_doc.xml · nonDerivative · entry 1

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,356

Read SEC document
November 09, 2020 Filed Nov 13, 2020 00:41 UTC
Foliano MichaelChief Financial Officer
Tax withholdingCommon Stock 511 $11.77 $6,014.47
Disclosure

SEC source: 0000926282-20-000022 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,416

Read SEC document
November 09, 2020 Filed Nov 13, 2020 00:24 UTC
STANTON THOMAS RDirector · Chairman and CEO
Tax withholdingCommon Stock 3,130 $11.77 $36,840.10
Disclosure

SEC source: 0000926282-20-000021 · primary_doc.xml · nonDerivative · entry 1

STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,728

Read SEC document
September 09, 2020 Filed Sep 10, 2020 14:36 UTC GrantCommon Stock 64.32 $10.34 $665.07
Disclosure

SEC source: 0000926282-20-000018 · primary_doc.xml · nonDerivative · entry 1

McCray Gregory James · CIK 0001327057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,180.437

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
September 09, 2020 Filed Sep 16, 2020 15:55 UTC
Centis RonaldSVP, Operations
GrantCommon Stock 3.077 $10.34 $31.82
Disclosure

SEC source: 0000926282-20-000020 · primary_doc.xml · nonDerivative · entry 2

Centis Ronald · CIK 0001769038 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,775.759

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
September 09, 2020 Filed Sep 16, 2020 15:49 UTC
Harris RayChief Information Officer
GrantCommon Stock 2.917 $10.34 $30.16
Disclosure

SEC source: 0000926282-20-000019 · primary_doc.xml · nonDerivative · entry 3

Harris Ray · CIK 0001766181 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,941.097

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 4, 2020 21:36 UTC GrantPhantom Stock · Derivative 143.618 $0.00 $0.00
Disclosure

SEC source: 0001300513-20-000001 · primary_doc.xml · derivative · entry 2

Foliano Michael · CIK 0001300513 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,367.349

Underlying: Common Stock · 143.618 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F3 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

F3 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

Read SEC document
September 03, 2020 Filed Sep 4, 2020 21:36 UTC GrantCommon Stock 1.974 $0.00 $0.00
Disclosure

SEC source: 0001300513-20-000001 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k) Plan

Disclosed balance after: 239.808

F1 · date: Dividends reinvested into common stock and held in 401(k) plan by Reporting Person.

Read SEC document
September 03, 2020 Filed Sep 4, 2020 19:41 UTC
STANTON THOMAS RChairman and CEO
GrantPhantom Stock · Derivative 817.271 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000011 · primary_doc.xml · derivative · entry 1

STANTON THOMAS R · CIK 0001191219 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,830.706

Underlying: Common Stock · 817.271 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 15:30 UTC GrantDividend Equivalent Rights · Derivative 79.235 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000014 · primary_doc.xml · derivative · entry 1

NICHOLS ROY J · CIK 0000937725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253.378

Underlying: Common Stock · 79.235 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 19:48 UTC GrantDividend Equivalent Rights · Derivative 79.235 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000017 · primary_doc.xml · derivative · entry 2

McCray Gregory James · CIK 0001327057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253.378

Underlying: Common Stock · 79.235 shares

Expires not disclosed

F2 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 19:34 UTC GrantDividend Equivalent Rights · Derivative 79.235 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000015 · primary_doc.xml · derivative · entry 1

Jacqueline Hourigan Rice · CIK 0001637150 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253.378

Underlying: Common Stock · 79.235 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 19:38 UTC GrantDividend Equivalent Rights · Derivative 79.235 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000016 · primary_doc.xml · derivative · entry 1

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253.378

Underlying: Common Stock · 79.235 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 19:25 UTC
Nair BalanDirector
GrantDividend Equivalent Rights · Derivative 79.235 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000013 · primary_doc.xml · derivative · entry 1

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253.378

Underlying: Common Stock · 79.235 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 19:21 UTC GrantDividend Equivalent Rights · Derivative 79.235 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000012 · primary_doc.xml · derivative · entry 1

HUSS H FENWICK · CIK 0001201037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253.378

Underlying: Common Stock · 79.235 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 12:55 UTC
Wilson James Denson JrChief Revenue Officer
GrantPhantom Stock · Derivative 137.389 $0.00 $0.00
Disclosure

SEC source: 0001300513-20-000002 · primary_doc.xml · derivative · entry 3

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,614.21

Underlying: Common Stock · 137.389 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F3 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

F3 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 12:55 UTC
Wilson James Denson JrChief Revenue Officer
GrantCommon Stock 32.776 $0.00 $0.00
Disclosure

SEC source: 0001300513-20-000002 · primary_doc.xml · nonDerivative · entry 2

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k) Plan

Disclosed balance after: 3,982.121

F1 · security: Dividends reinvested into common stock and held in 401(k) plan by Reporting Person.

Read SEC document
June 09, 2020 Filed Sep 8, 2020 19:48 UTC GrantCommon Stock 56.049 $11.78 $660.26
Disclosure

SEC source: 0000926282-20-000017 · primary_doc.xml · nonDerivative · entry 1

McCray Gregory James · CIK 0001327057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,116.12

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
June 09, 2020 Filed Sep 16, 2020 15:55 UTC
Centis RonaldSVP, Operations
GrantCommon Stock 2.682 $11.78 $31.59
Disclosure

SEC source: 0000926282-20-000020 · primary_doc.xml · nonDerivative · entry 1

Centis Ronald · CIK 0001769038 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,772.682

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
June 09, 2020 Filed Sep 16, 2020 15:49 UTC
Harris RayChief Information Officer
GrantCommon Stock 2.542 $11.78 $29.94
Disclosure

SEC source: 0000926282-20-000019 · primary_doc.xml · nonDerivative · entry 2

Harris Ray · CIK 0001766181 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,938.18

F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 11:02 UTC GrantDividend Equivalent Rights · Derivative 72.031 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000002 · primary_doc.xml · derivative · entry 1

NICHOLS ROY J · CIK 0000937725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174.143

Underlying: Common Stock · 72.031 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 20:58 UTC GrantDividend Equivalent Rights · Derivative 131.571 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000010 · primary_doc.xml · derivative · entry 2

Foliano Michael · CIK 0001300513 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,223.731

Underlying: Common Stock · 131.571 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F3 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

F3 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 20:58 UTC GrantCommon Stock 1.794 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000010 · primary_doc.xml · nonDerivative · entry 1

Foliano Michael · CIK 0001300513 · CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k) plan

Disclosed balance after: 237.834

F1 · security: Dividends reinvested into common stock and held in 401(k) plan by Reporting Person.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 19:44 UTC
Wilson James Denson JrChief Revenue Officer
GrantPhantom Stock · Derivative 125.866 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000009 · primary_doc.xml · derivative · entry 1

Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,476.821

Underlying: Common Stock · 125.866 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F2 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

F2 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 19:09 UTC
STANTON THOMAS RChairman and CEO
GrantPhantom Stock · Derivative 748.72 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000008 · primary_doc.xml · derivative · entry 1

STANTON THOMAS R · CIK 0001191219 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,013.435

Underlying: Common Stock · 748.72 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof.

F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 18:20 UTC GrantDividend Equivalent Rights · Derivative 72.031 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000007 · primary_doc.xml · derivative · entry 1

McCray Gregory James · CIK 0001327057 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174.143

Underlying: Common Stock · 72.031 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 17:59 UTC GrantDividend Equivalent Rights · Derivative 72.031 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000006 · primary_doc.xml · derivative · entry 1

Jacqueline Hourigan Rice · CIK 0001637150 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174.143

Underlying: Common Stock · 72.031 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 16:55 UTC GrantDividend Equivalent Rights · Derivative 72.031 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000005 · primary_doc.xml · derivative · entry 1

Walker Kathryn A · CIK 0001264261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174.143

Underlying: Common Stock · 72.031 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 16:00 UTC
Nair BalanDirector
GrantDividend Equivalent Rights · Derivative 72.031 $0.00 $0.00
Disclosure

SEC source: 0000926282-20-000004 · primary_doc.xml · derivative · entry 1

Nair Balan · CIK 0001398905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174.143

Underlying: Common Stock · 72.031 shares

Expires not disclosed

F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.